My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 446

    1.

    Trichloroethylene cancer epidemiology: a consideration of select issues.

    Scott CS, Chiu WA.

    Environ Health Perspect. 2006 Sep;114(9):1471-8. Review.PMID: 16966107 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

    Caldwell JC, Keshava N.

    Environ Health Perspect. 2006 Sep;114(9):1457-63. Review.PMID: 16966105 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Key scientific issues in the health risk assessment of trichloroethylene.

    Chiu WA, Caldwell JC, Keshava N, Scott CS.

    Environ Health Perspect. 2006 Sep;114(9):1445-9. Review.PMID: 16966103 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.

    Keshava N, Caldwell JC.

    Environ Health Perspect. 2006 Sep;114(9):1464-70. Review.PMID: 16966106 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.

    Clewell HJ, Andersen ME.

    Crit Rev Toxicol. 2004 Sep-Oct;34(5):385-445. Review.PMID: 15560567 [PubMed - indexed for MEDLINE]Related articles

    6.

    Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.

    Caldwell JC, Keshava N, Evans MV.

    Environ Mol Mutagen. 2008 Mar;49(2):142-54. Review.PMID: 17973308 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and Andersen.

    Caldwell JC, Evans MV, Marcus AH, Scott CS, Chiu WA, Okino MS, Preuss PW.

    Crit Rev Toxicol. 2006 Mar;36(3):291-4; discussion 295-8.PMID: 16686425 [PubMed - indexed for MEDLINE]Related articles

    8.

    Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.

    Bogen KT, Gold LS.

    Regul Toxicol Pharmacol. 1997 Feb;25(1):26-42. Review.PMID: 9056499 [PubMed - indexed for MEDLINE]Related articles

    9.

    Issues in the pharmacokinetics of trichloroethylene and its metabolites.

    Chiu WA, Okino MS, Lipscomb JC, Evans MV.

    Environ Health Perspect. 2006 Sep;114(9):1450-6. Review.PMID: 16966104 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.

    Moore MM, Harrington-Brock K.

    Environ Health Perspect. 2000 May;108 Suppl 2:215-23. Review.PMID: 10807553 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Trichloroethylene and cancer: epidemiologic evidence.

    Wartenberg D, Reyner D, Scott CS.

    Environ Health Perspect. 2000 May;108 Suppl 2:161-76. Review.PMID: 10807550 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A meta-analysis of occupational trichloroethylene exposure and liver cancer.

    Alexander DD, Kelsh MA, Mink PJ, Mandel JH, Basu R, Weingart M.

    Int Arch Occup Environ Health. 2007 Nov;81(2):127-43. Epub 2007 May 10. Review.PMID: 17492303 [PubMed - indexed for MEDLINE]Related articles

    13.

    Carcinogenicity of trichloroethylene: an epidemiologic assessment.

    Wong O.

    Clin Occup Environ Med. 2004 Aug;4(3):557-89, vii. Review.PMID: 15325321 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetic signature for human risk assessment: lessons from trichloroethylene.

    Shiao YH.

    Environ Mol Mutagen. 2009 Jan;50(1):68-77. Review.PMID: 19031419 [PubMed - indexed for MEDLINE]Related articles

    15.

    The perils and promise of modern risk assessment: the example of trichloroethylene.

    Kester JE, Clewell HJ 3rd.

    Clin Occup Environ Med. 2004 Aug;4(3):497-512, vi-vii.PMID: 15325318 [PubMed - indexed for MEDLINE]Related articles

    16.

    Potential human cancer risks from exposure to PCBs: a tale of two evaluations.

    Golden R, Doull J, Waddell W, Mandel J.

    Crit Rev Toxicol. 2003;33(5):543-80. Review. Erratum in: Crit Rev Toxicol. 2004 Mar-Apr;34(2):209. PMID: 14594106 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nested case-control study of occupational chemical exposures and prostate cancer in aerospace and radiation workers.

    Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B.

    Am J Ind Med. 2007 May;50(5):383-90.PMID: 17407146 [PubMed - indexed for MEDLINE]Related articles

    18.

    A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer.

    McLaughlin JK, Blot WJ.

    Int Arch Occup Environ Health. 1997;70(4):222-31. Review.PMID: 9342621 [PubMed - indexed for MEDLINE]Related articles

    19.

    Estimating the risks of liver and lung cancer in humans exposed to trichloroethylene using a physiological model.

    Fisher JW.

    Toxicol Lett. 1993 May;68(1-2):127-9.PMID: 8516759 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improving the use of epidemiologic data in health risk assessment.

    Erdreich LS, Burnett C.

    Toxicol Ind Health. 1985 Dec;1(4):65-81.PMID: 3843512 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity